The FY2026 Budget Fight Is Over. Here Is What Grant Seekers Won and Lost.
March 10, 2026 · 8 min read
Jared Klein
After months of shutdown threats, continuing resolutions, and political brinkmanship, Congress finally passed the FY2026 Consolidated Appropriations Act — and the research community can exhale, at least partially. The final bill represents a bipartisan rejection of the administration's most dramatic proposed cuts while quietly eliminating entire categories of funding that thousands of organizations depend on.
The headline numbers look reassuring. The National Institutes of Health received $48.7 billion, a $415 million increase over FY2025 and a decisive rebuke to the administration's proposal to slash NIH by $18 billion — roughly 40 percent. The Department of Education got $79 billion, $217 million above last year and approximately $12 billion above the White House request. Pell Grants held at $7,395 maximum.
But the bill that passed is not the bill that was proposed, and the distance between the two reveals everything about where federal grant funding is actually heading.
What Congress Preserved — and Why It Matters
NIH funding: $48.7 billion. The near-1-percent increase is modest in absolute terms, but its significance is enormous in context. The administration proposed cutting NIH to roughly $29 billion — a reduction that would have been the most devastating blow to American biomedical research since the agency's creation. That Congress not only rejected the cut but added funding reflects genuine bipartisan consensus that NIH remains untouchable in appropriations, even when the executive branch treats it as expendable in budget proposals. For grant seekers, this means the fundamental NIH funding pipeline remains intact. New R01 submissions, competing renewals, and program project grants will continue to flow at historical volumes, assuming the review process itself — which has been bottlenecked by political appointee oversight — can return to normal pace.
The indirect cost rate cap: blocked. This is arguably the single most important provision in the entire bill for research universities. In February 2025, NIH published guidance imposing a 15 percent indirect cost rate for grants to higher education institutions — a policy that would have cost universities billions in facilities and administrative reimbursement. A federal court permanently enjoined the policy in April 2025, and Congress codified that protection in the FY2026 bill, explicitly preserving current NIH indirect cost policies and requiring notification before any future policy changes. For universities that depend on indirect cost recovery to fund laboratory infrastructure, compliance offices, and research administration, this is not an abstract budget line. It is the difference between running a viable research enterprise and having to subsidize every federal grant with institutional funds. The bill's language — prohibiting changes to current indirect cost policy — gives institutions a legislative backstop that the court injunction alone could not guarantee.
Congressional accountability mandates. In an unusual move, Congress included language requiring the administration to "maintain enough staff to support agency and program responsibilities" at NIH, provide notification before changing grants policies, maintain current funding policies for international grantees, and prohibit forward funding of multiyear grants. These provisions read as a direct response to the staffing crisis and review bottlenecks that plagued NIH throughout FY2025. For researchers, they signal congressional awareness that the problem is not just funding levels but operational capacity — and that Congress is willing to use appropriations riders to enforce minimum standards of agency function.
Education programs: TRIO, GEAR UP, MSIs. Congress rejected proposals to eliminate or significantly reduce programs supporting low-income and underrepresented students, including TRIO, GEAR UP, Federal Supplemental Educational Opportunity Grants, and Title III/Title V funding for Minority-Serving Institutions (HBCUs, Hispanic Serving Institutions, Tribal Colleges). The Institute of Education Sciences received $790 million — triple the administration's $261 million request. The Office for Civil Rights received $140 million against a proposed $49 million cut. For nonprofit organizations, community colleges, and universities that rely on these programs for student support services and institutional development, the message is clear: these programs have durable congressional support that survives even aggressive executive proposals.
BARDA: $1.05 billion. The Biomedical Advanced Research and Development Authority received a $35 million increase, reflecting continued bipartisan investment in pandemic preparedness and medical countermeasure development — an area where the political calculus still favors spending after COVID-19.
What Congress Cut — and Who Is Affected
The victories for research and education funding came at a cost, and the sectors that lost reveal the administration's priorities that Congress was willing to accommodate.
Clean energy demonstrations: eliminated. The Office of Clean Energy Demonstrations, created under the Bipartisan Infrastructure Law to accelerate deployment of clean hydrogen, carbon capture, and advanced nuclear technologies, was zeroed out. For clean energy startups, engineering firms, and research labs that had been positioning for demonstration-scale federal funding, this is a hard stop. The billions authorized under the Infrastructure Investment and Jobs Act for these purposes will not be appropriated, at least not in FY2026. Organizations in the clean energy space need to pivot toward DOE's remaining research offices, state-level clean energy programs, and private philanthropy.
Environmental justice: eliminated. The EPA's Environmental Justice program was zeroed out, and DOE's Office of Energy Justice and Equity was eliminated. This does not mean all environmental funding disappeared — the EPA's broader programs continue, and the EPA Inspector General recently validated the Community Change Grants program's selection process. But dedicated environmental justice funding streams that environmental nonprofits and community organizations built programs around are gone at the federal level.
Global health security: reduced. Global health security programming was cut $84.4 million, the Global Fund contribution decreased $400 million, and global TB programming was cut nearly $16 million. For international health NGOs and university global health programs, the message is that pandemic preparedness funding favors domestic programs (BARDA) over international ones.
Renewable energy pivot. The bill signals a broader DOE shift away from renewable energy toward critical minerals, domestic production, and nuclear weapons modernization, which received over $20 billion. This is not a cut to DOE overall — it is a rebalancing that advantages different applicant pools. Materials scientists, mining engineers, nuclear physicists, and defense contractors benefit. Solar developers, wind energy researchers, and grid-integration startups lose ground.
Reading Between the Lines
Three patterns in the FY2026 bill deserve attention from anyone planning a grant strategy over the next 12 to 24 months.
Bipartisan floors are real but static. NIH, NSF, TRIO, and Pell Grants have genuine bipartisan support that prevents catastrophic cuts. But "preventing catastrophic cuts" is different from "keeping pace with inflation." The $415 million NIH increase amounts to less than 1 percent — well below the rate of biomedical cost inflation. In real purchasing power, NIH funding continues a gradual decline that has been underway since the doubling era ended in 2003. Researchers should treat federal funding as stable but not growing, and plan their lab finances accordingly.
The executive proposal is a negotiating anchor, not a budget. Every year, the administration proposes and Congress disposes. But the proposals matter because they reveal which programs the executive branch would eliminate if it could. Programs that appeared on the chopping block — environmental justice, clean energy demonstrations, international health — remain politically vulnerable even after Congress restored them this year. Organizations in these sectors should diversify aggressively toward state, foundation, and private funding sources rather than assuming Congress will save them indefinitely.
Operational capacity is the real constraint. The most important provisions in the FY2026 bill may not be the funding numbers but the accountability language requiring NIH to maintain adequate staffing and provide notification before policy changes. The grant-seeking community's biggest problem in FY2025 was not that money disappeared — it was that review panels were delayed, program officers were reassigned, and political clearance requirements created months-long backlogs. Even with full funding restored, the operational capacity of federal agencies to actually issue awards on time remains an open question.
A Practical Strategy for FY2026
If you are an NIH-funded researcher: Your funding stream is stable. The bigger risk is operational — delayed reviews, slow award processing, and uncertainty about timeline. Submit your proposals on schedule, but build contingency into your lab budget for potential gaps between award periods. Build state-level funding relationships as a hedge.
If you are a university research administrator: The indirect cost protection is your biggest win. Document everything about your F&A rate negotiations and maintain records that demonstrate the institutional cost of research operations. Congress wrote the protection into law for now, but administrative proposals to cap indirect costs will return — having well-documented justification ready for the next fight is essential.
If you are in clean energy or environmental justice: Federal funding in your sector just got harder. Pivot toward the DOE offices that survived (Office of Science, ARPA-E, Loan Programs Office), state clean energy programs that are expanding to fill federal gaps, and foundation funding. The Inflation Reduction Act's tax credits remain law even if appropriated program funding is cut — structure your work to leverage tax incentives rather than relying on direct federal grants.
If you are a community-based nonprofit: Programs like TRIO, GEAR UP, and Title III/V survived intact. Apply aggressively — the programs are funded, and continued strong application volumes help justify their budgets in future years. Every unfilled slot is an argument for opponents who want to cut the programs next time.
If you work in defense or critical minerals: You are in the funding sweet spot. DOE's nuclear modernization budget is at historic highs, critical minerals funding is expanding, and defense SBIR/STTR programs are ramping up after reauthorization. Position your proposals around national security, supply chain resilience, and domestic manufacturing — these are the keywords that unlock funding in the current political environment.
The Long View
The FY2026 appropriations bill is neither a disaster nor a triumph. It is a holding action — Congress maintaining the basic infrastructure of federal research and education funding while the executive branch pushes for transformative cuts that lack the votes to pass.
For grant seekers, the practical takeaway is straightforward: the money is there, but the operational environment remains unpredictable. The organizations that will thrive are those diversifying beyond any single federal agency, building state-level funding relationships, and maintaining the administrative capacity to submit proposals quickly when windows open.
The era of assuming federal grants would always be there, always be processed on time, and always grow with inflation is over. What replaces it is a more complex, more competitive, and more politically contingent funding landscape — one where strategic planning matters as much as scientific merit.
Tools like Granted can help you navigate this complexity by surfacing opportunities across federal, state, and foundation sources in a single search, so you spend less time hunting for grants and more time writing winning proposals.